Status:
COMPLETED
Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tonsillectomy
Eligibility:
All Genders
12-25 years
Phase:
NA
Brief Summary
This study will evaluate whether lowering the default number of doses for opioid prescriptions written in an electronic health record system can decrease opioid prescribing without causing unintended ...
Eligibility Criteria
Inclusion
- Adolescents and young adults aged 12-25 years undergoing tonsillectomy at C.S. Mott Hospital, University Hospital, Brighton Center for Specialty Care, or Livonia Center for Specialty Care from October 2019-July 2021, excluding April-May 2020 (owing to suspension of elective procedures due to COVID-19).
- Surgeon belongs to the Department of Otolaryngology at the University of Michigan Medical School
- Patients are not any of the following: patients living in foster care or with a legal guardian, patients with medical complexity or developmental delays, non-English speaking patients, patients with recent suicidal ideation documented in their chart, or patients undergoing emergent tonsillectomy.
Exclusion
- Patients with prescription opioid use prior to surgery
- Patients undergoing additional procedures at the same time as tonsillectomy (other than minor procedures such as tympanostomy tube placement)
- Patients enrolled in another study
- Patients who are not prescribed opioids post-operatively at discharge
- Patients who are enrolled in the Michigan Pain-control Optimization Pathway (M-POP), which includes education about pain management and a small initial opioid prescription
- Patients with hospitalization with length of stay \> 1 day after surgery
- Patients who decline to enroll
- Additional exclusion criteria for secondary analysis: Patients who do not complete the baseline and post-operative day 14 surveys
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT04066829
Start Date
October 1 2019
End Date
July 31 2021
Last Update
November 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Michigan
Ann Arbor, Michigan, United States, 48109